Menu
Login

Report Library

All Reports

Antibiotics: An Analysis of Approved Drugs, Pipelines, and Likelihood of Approval

September 29, 2014

This report provides an analysis of approved drugs, pipelines, and FDA approvability for drugs for the treatment or prevention of bacterial infections. This analysis includes:
  • The FDA likelihood of approval (LOA) of antibiotics and bacterial vaccines compared to LOAs for drugs for infectious disease indications as a whole and drugs as a whole.
  • A breakdown of antibiotics by approval year, development phase, molecule type, indication, and lead sponsor market cap.
  • Comparisons of antibiotics approved since 2000 with antibiotics currently in development.
For the full report, please download the PDF version at the top of this page.

For our disclosures, please read the BioMedTracker Research Standards.
Disease Group Covered: Infectious Disease

 Additional Resources: